GeminIQ Website Logo

Viewing CBIH free

Start free trial

Subscribe for full history, 90+ metrics, screener, watchlist...

Cannabis Bioscience International Holdings, Inc.

CBIH

Companies in Services-Commercial Physical & Biological Research

IQVINCYMEDPCRLABSINRC

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2026-02-28
2025-11-30
2025-08-31
2025-05-31
2025-02-28
2024-08-31
2024-05-31
2024-02-29
2023-11-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
000000000
Accounts Receivable Net Current
000000000
Assets Current
Assets Current
000000000
Other Receivables Net Current
0000--0--
Other Assets Current
00000000-
Operating Lease Right Of Use Asset
000000000
Assets
000000000
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current
000000000
Bank Overdrafts
---000000
Deferred Revenue Current
------000
Deferred Revenue
--0------
Interest Payable Current
0000--0--
Liabilities Current
Liabilities Current
111111111
Other Short Term Borrowings
000000000
Loans Payable Current
000000000
Other Loans Payable Current
-------0-
Derivative Liabilities Current
00000-0--
Operating Lease Liability Current
000000000
Convertible Notes Payable Current
0000--0--
Notes Payable
---00-0--
Liabilities Noncurrent
Liabilities Noncurrent
000000000
Long Term Loans Payable
000000000
Operating Lease Liability Noncurrent
---000000
Liabilities
111111111
Preferred Stock Value
000000000
Common Stock Value
000000000
Stockholders Equity
Additional Paid In Capital
555544444
Stockholders Equity
-1-1-1-1-1-1-1-1-1
Retained Earnings Accumulated Deficit
-6-6-6-6-6-5-5-5-5
Liabilities And Stockholders Equity
000000000
Preferred Stock Shares Authorized
101010101010101010
Preferred Stock Shares Outstanding
---0000--
Common Stock Shares Authorized
20,00020,00020,00020,00020,00020,00020,00020,00020,000
Common Stock Shares Issued
11,62711,62711,62711,62710,93210,55710,43210,432-
Shares Outstanding
11,62711,62711,62711,62710,93210,55710,43210,43210,332

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20260.00%40.00%40.00%12.50%0.00%-25.00%-25.00%0.00%-25.00%---
2025-7.14%-14.29%-14.29%----14.29%-14.29%-14.29%8.70%8.70%52.17%
2024---20.00%80.00%30.00%0.00%-8.33%50.00%-13.33%-16.00%-20.00%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics
2026-02-28
2025-11-30
2025-08-31
2025-05-31
2025-02-28
2024-08-31
2024-05-31
2024-02-29
2023-11-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.00
0.02
0.02
0.03
0.00
0.02
0.02
0.02
0.03
Quick Ratio
0.00
0.02
0.02
0.03
0.00
0.02
0.02
0.02
0.03
Working Capital
-1.22M
-1.11M
-996.73K
-916.88K
-966.27K
-833.35K
-860.42K
-782.62K
-640.57K
Leverage & Debt
Debt to Equity
-1.00
-1.02
-1.02
-1.03
-1.01
-1.04
-1.05
-1.10
-1.12
Interest Coverage TTM
-2.91
-2.92
-3.23
-2.71
-3.45
-3.13
-7.67
15.35
119.05
Debt Ratio
951.21
62.60
66.79
37.50
83.33
23.80
19.88
11.39
9.27
Efficiency & Turnover
Asset Turnover TTM
24.09
5.89
8.60
7.18
6.49
0.01
0.16
0.46
406.98
Days Sales Outstanding TTM
3.60
35.29
16.23
9.46
10.62
9,756.03
983.27
328.17
0.17
Receivables Turnover TTM
101.32
10.34
22.49
38.57
34.38
0.04
0.37
1.11
2,136.16
Per Share Metrics
Diluted EPS TTM
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
0.00
0.00
Free Cash Flow Per Share TTM
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
-0.00
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
82.80%
75.01%
85.25%
86.98%
84.62%
87.38%
22.93%
28.43%
31.50%
Operating Profit Margin TTM
-231.69%
-245.25%
-151.62%
-144.57%
-163.22%
-136.48%
-17.08%
6.45%
15.40%
Net Profit Margin TTM
-300.60%
-333.39%
-192.98%
-191.84%
-207.03%
-170.12%
-21.46%
0.95%
8.54%
Growth Metrics
Net Revenue Growth (1Y)
-47.78%
-52.87%
-96.29%
-98.13%
-99.09%
-
-
-
-
Net Income Growth (1Y)
-24.18%
-7.63%
-66.64%
-475.75%
-122.16%
-
-
-
-
EPS Growth (1Y)
-30.05%
-16.91%
-70.40%
-463.69%
-121.34%
-
-
-
-
Valuation Metrics
P/E TTM
-7.82
-8.65
-12.89
-7.42
-10.26
-12.22
-3.27
33.73
2.48
P/B TTM
-3.17
-4.26
-6.53
-5.53
-6.56
-8.42
-5.74
-7.97
-10.43
P/S TTM
23.50
28.84
24.87
14.23
21.23
20.78
0.70
0.32
0.21
Market Cap
4.65M
5.81M
8.14M
6.43M
8.04M
8.89M
6.19M
7.78M
8.78M
Enterprise Value
4.67M
5.83M
8.16M
6.44M
8.08M
8.90M
6.20M
7.79M
8.79M
Calculated Values
Free Cash Flow TTM
-268.11K
-438.83K
-463.75K
-534.48K
-399.24K
-509.80K
-2.07M
-3.14M
-2.65M
Net Debt
14.50K
14.56K
20.73K
10.82K
34.96K
6.09K
6.30K
6.26K
11.74K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial
No insider data available.

Subscribe to unlock 17+ years of data

Start free trial
No institutional ownership data available.

Cannabis Bioscience International Holdings, Inc. (CBIH) — SEC Financial Statements & Analysis

Cannabis Bioscience International Holdings, Inc. (CBIH) is a services-commercial physical & biological research company, incorporated in CO. Cannabis Bioscience International Holdings, Inc. trades on OTC as: CBIH. Based on its latest SEC filing (Form 10-Q, period ending 2026-02-28), Cannabis Bioscience International Holdings, Inc. reported a -47.78% year-over-year revenue growth, a Gross Profit Margin of 82.80% (TTM), a Debt-to-Equity ratio of -1.00x, a Price-to-Sales (P/S) ratio of 23.50x (TTM), a Price-to-Book (P/B) ratio of -3.17 (TTM), at a market cap of $4.65M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-47.78%
Gross Profit Margin TTM
82.80%
Debt To Equity
-1.00x
P/S TTM
23.50x
P/B TTM
-3.17
Market Cap
$4.65M

Data as of 2026-02-28 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Cannabis Bioscience International Holdings, Inc. in?

Cannabis Bioscience International Holdings, Inc. (CBIH) operates in the Services-Commercial Physical & Biological Research industry.

What is CBIH's market cap?

Cannabis Bioscience International Holdings, Inc. (CBIH) has a market capitalization of $4.65M as of 2026-02-28.

What exchange does CBIH trade on?

Cannabis Bioscience International Holdings, Inc. (CBIH) trades on the OTC.

Where is Cannabis Bioscience International Holdings, Inc. incorporated?

Cannabis Bioscience International Holdings, Inc. is incorporated in CO.

Research Faster.
Invest Smarter.

Start 7-day free trial

Cannabis Bioscience International Holdings, Inc. (CBIH) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.